119 related articles for article (PubMed ID: 36001923)
1. Construction of the prognostic enhancer RNA regulatory network in osteosarcoma.
Yan P; Li Z; Xian S; Wang S; Fu Q; Zhu J; Yue X; Zhang X; Chen S; Zhang W; Lu J; Yin H; Huang R; Huang Z
Transl Oncol; 2022 Nov; 25():101499. PubMed ID: 36001923
[TBL] [Abstract][Full Text] [Related]
2. Identification of Key eRNAs for Spinal Cord Injury by Integrated Multinomial Bioinformatics Analysis.
Huang R; Wang S; Zhu R; Xian S; Huang Z; Cheng L; Zhang J
Front Cell Dev Biol; 2021; 9():728242. PubMed ID: 34708039
[No Abstract] [Full Text] [Related]
3. Identification of the enhancer RNAs related to tumorgenesis of pituitary neuroendocrine tumors.
Wang L; Wei C; Wang Y; Huang N; Zhang T; Dai Y; Xue L; Lin S; Wu ZB
Front Endocrinol (Lausanne); 2023; 14():1149997. PubMed ID: 37534217
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Ability of Enhancer RNAs in Metastasis of Non-Small Cell Lung Cancer.
Liu J; Jia J; Wang S; Zhang J; Xian S; Zheng Z; Deng L; Feng Y; Zhang Y; Zhang J
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807355
[TBL] [Abstract][Full Text] [Related]
5. Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma
Huang R; Huang D; Wang S; Xian S; Liu Y; Jin M; Zhang X; Chen S; Yue X; Zhang W; Lu J; Liu H; Huang Z; Zhang H; Yin H
Front Genet; 2022; 13():952162. PubMed ID: 36092920
[No Abstract] [Full Text] [Related]
6. Identification of key eRNAs for intervertebral disc degeneration by integrated multinomial bioinformatics analysis.
Li Y; Huang R; Ye J; Han X; Meng T; Song D; Yin H
BMC Musculoskelet Disord; 2024 May; 25(1):356. PubMed ID: 38704519
[TBL] [Abstract][Full Text] [Related]
7. Enhancer RNA SLIT2 Inhibits Bone Metastasis of Breast Cancer Through Regulating P38 MAPK/c-Fos Signaling Pathway.
Li P; Lin Z; Liu Q; Chen S; Gao X; Guo W; Gong F; Wei J; Lin H
Front Oncol; 2021; 11():743840. PubMed ID: 34722297
[TBL] [Abstract][Full Text] [Related]
8. Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in Lung Squamous Cell Carcinoma.
Zhao S; Liu Q; Li J; Hu C; Cao F; Ma W; Gao J
DNA Cell Biol; 2021 Dec; 40(12):1563-1583. PubMed ID: 34931870
[TBL] [Abstract][Full Text] [Related]
9. Construction of Metastasis-Specific Regulation Network in Ovarian Cancer Based on Prognostic Stemness-Related Signatures.
Wang W; Guo H; Wu S; Xian S; Zhang W; Zhang R; Chen Z; Su K; Zhang Y; Zhu Y; Chu D; Zhao M; Tang Z; Zheng C; Huang Z; Ma Q; Guo R
Reprod Sci; 2023 Sep; 30(9):2634-2654. PubMed ID: 36940084
[TBL] [Abstract][Full Text] [Related]
10. Development of novel gene signatures for the risk stratification of prognosis and diagnostic prediction of osteosarcoma patients using bioinformatics analysis.
Li G; Huang B; Wu H; Zhang H
Transl Cancer Res; 2022 Jul; 11(7):2374-2387. PubMed ID: 35966307
[TBL] [Abstract][Full Text] [Related]
11. DCP1A is an unfavorable prognostic-related enhancer RNA in hepatocellular carcinoma.
Wu H; Zhang J; Bai Y; Zhang S; Zhang Z; Tong W; Han P; Fu B; Zhang Y; Shen Z
Aging (Albany NY); 2021 Oct; 13(19):23020-23035. PubMed ID: 34609335
[TBL] [Abstract][Full Text] [Related]
12. A four-enhancer RNA-based prognostic signature for thyroid cancer.
Liang Y; Zhang Q; Xin T; Zhang DL
Exp Cell Res; 2022 Mar; 412(2):113023. PubMed ID: 35033555
[TBL] [Abstract][Full Text] [Related]
13. Single-Cell RNA Sequencing Revealed a 3-Gene Panel Predicted the Diagnosis and Prognosis of Thyroid Papillary Carcinoma and Associated With Tumor Immune Microenvironment.
Chen Z; Wang Y; Li D; Le Y; Han Y; Jia L; Yan C; Tian Z; Song W; Li F; Zhao K; He X
Front Oncol; 2022; 12():862313. PubMed ID: 35359404
[TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma.
Cai S; Hu X; Chen R; Zhang Y
Front Genet; 2021; 12():657051. PubMed ID: 34178028
[TBL] [Abstract][Full Text] [Related]
15. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
Front Immunol; 2022; 13():919231. PubMed ID: 35967366
[TBL] [Abstract][Full Text] [Related]
16. An integrated analysis of enhancer RNAs in glioma and a validation of their prognostic values.
Lin H; Yang Y; Hou C; Zheng J; Lv G; Mao R; Xu P; Chen S; Zhou Y; Wang P; Zhou D
Am J Transl Res; 2021; 13(8):8611-8631. PubMed ID: 34539983
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.
Qin N; Ma Z; Wang C; Zhang E; Li Y; Huang M; Chen C; Zhang C; Fan J; Gu Y; Xu X; Yang L; Wei X; Yin R; Jiang Y; Dai J; Jin G; Xu L; Hu Z; Shen H; Ma H
Theranostics; 2020; 10(24):11264-11277. PubMed ID: 33042282
[No Abstract] [Full Text] [Related]
18. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
[No Abstract] [Full Text] [Related]
19. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes.
Guo J; Li X; Shen S; Wu X
Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564
[TBL] [Abstract][Full Text] [Related]
20. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
Hu J; Wang T; Chen Q
Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
